You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 14, 2024

CLINICAL TRIALS PROFILE FOR DIAZOXIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Diazoxide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004825 ↗ Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism Completed Children's Hospital of Philadelphia N/A 1998-05-01 OBJECTIVES: I. Confirm the inhibitory effect of recombinant human insulin-like growth factor I (IGF-I) on insulin secretion in children with hyperinsulinism. II. Define the effects of short term IGF-I therapy on postprandial blood sugar levels in this patient population. III. Characterize the effects of short term IGF-I therapy on fasting behavior, and other insulin dependent parameters, in this patient population.
NCT00004825 ↗ Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism Completed FDA Office of Orphan Products Development N/A 1998-05-01 OBJECTIVES: I. Confirm the inhibitory effect of recombinant human insulin-like growth factor I (IGF-I) on insulin secretion in children with hyperinsulinism. II. Define the effects of short term IGF-I therapy on postprandial blood sugar levels in this patient population. III. Characterize the effects of short term IGF-I therapy on fasting behavior, and other insulin dependent parameters, in this patient population.
NCT00131755 ↗ Efficacy of Diazoxide in Type 1 Diabetes Completed Grill, Valdemar, M.D. Phase 4 2005-02-01 The purpose of this study is to find out if Diazoxide can partly retain insulin production in newly diagnosed type 1 diabetes patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Diazoxide

Condition Name

Condition Name for Diazoxide
Intervention Trials
Prader-Willi Syndrome 6
Hypertriglyceridemia 5
Glucose, High Blood 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Diazoxide
Intervention Trials
Hyperinsulinism 8
Hypoglycemia 7
Syndrome 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Diazoxide

Trials by Country

Trials by Country for Diazoxide
Location Trials
United States 64
United Kingdom 7
Netherlands 3
France 2
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Diazoxide
Location Trials
New York 9
California 7
Maryland 4
Colorado 3
Texas 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Diazoxide

Clinical Trial Phase

Clinical Trial Phase for Diazoxide
Clinical Trial Phase Trials
Phase 4 6
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Diazoxide
Clinical Trial Phase Trials
Completed 21
Withdrawn 5
Not yet recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Diazoxide

Sponsor Name

Sponsor Name for Diazoxide
Sponsor Trials
Essentialis, Inc. 8
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Albert Einstein College of Medicine 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Diazoxide
Sponsor Trials
Other 40
Industry 19
NIH 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.